Cape Investment Advisory, Inc. Abbott Laboratories Transaction History
Cape Investment Advisory, Inc.
- $223 Billion
- Q2 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 1,160 shares of ABT stock, worth $132,808. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,160
Previous 1,157
0.26%
Holding current value
$132,808
Previous $132 Million
8.37%
% of portfolio
0.05%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,164Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.52 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.22 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.55 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...